DK142343B - Fremgangsmåde til fremstilling af en vaccine ved dyrkning af mikroorganismer, navnlig virus, i eucaryotiske celler. - Google Patents

Fremgangsmåde til fremstilling af en vaccine ved dyrkning af mikroorganismer, navnlig virus, i eucaryotiske celler. Download PDF

Info

Publication number: DK142343B
Authority: DK; Denmark
Prior art keywords: cells; medium; virus; culture; bed
Prior art date: 1972-04-26

Application number

DK55175A

Other languages

Danish (da)

English (en)

Other versions

DK142343C (xx

DK55175A (xx

Inventor

Ronald Charles Telling

Roy John Passingham

Brian Lewis Kitchener

David George Hopkinson

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-04-26

Filing date

1975-02-14

Publication date

1980-10-20

1972-04-26 Priority claimed from GB1938772A external-priority patent/GB1436323A/en

1975-02-14 Application filed by Wellcome Found filed Critical Wellcome Found

1975-02-14 Priority to DK55175A priority Critical patent/DK142343B/da

1975-08-04 Publication of DK55175A publication Critical patent/DK55175A/da

1980-10-20 Publication of DK142343B publication Critical patent/DK142343B/da

1981-07-20 Application granted granted Critical

1981-07-20 Publication of DK142343C publication Critical patent/DK142343C/da

Links

241000700605 Viruses Species 0.000 title claims description 57
238000000034 method Methods 0.000 title claims description 21
244000005700 microbiome Species 0.000 title claims description 14
229960005486 vaccine Drugs 0.000 title claims description 14
238000002360 preparation method Methods 0.000 title claims description 4
210000004027 cell Anatomy 0.000 claims description 87
239000002609 medium Substances 0.000 claims description 51
230000012010 growth Effects 0.000 claims description 19
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 16
230000014759 maintenance of location Effects 0.000 claims description 13
239000005909 Kieselgur Substances 0.000 claims description 12
235000015097 nutrients Nutrition 0.000 claims description 10
230000003612 virological effect Effects 0.000 claims description 10
241000283690 Bos taurus Species 0.000 claims description 8
239000010410 layer Substances 0.000 claims description 8
239000002356 single layer Substances 0.000 claims description 5
239000000427 antigen Substances 0.000 claims description 4
102000036639 antigens Human genes 0.000 claims description 4
108091007433 antigens Proteins 0.000 claims description 4
239000012888 bovine serum Substances 0.000 claims description 4
239000006143 cell culture medium Substances 0.000 claims description 4
238000002255 vaccination Methods 0.000 claims description 4
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 3
238000012258 culturing Methods 0.000 claims description 3
210000003292 kidney cell Anatomy 0.000 claims description 3
239000007788 liquid Substances 0.000 claims description 3
239000011236 particulate material Substances 0.000 claims description 3
239000011148 porous material Substances 0.000 claims description 3
239000001397 quillaja saponaria molina bark Substances 0.000 claims description 3
229930182490 saponin Natural products 0.000 claims description 3
150000007949 saponins Chemical class 0.000 claims description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
239000008103 glucose Substances 0.000 claims description 2
239000002699 waste material Substances 0.000 claims description 2
AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 claims 1
239000002054 inoculum Substances 0.000 claims 1
229940031418 trivalent vaccine Drugs 0.000 claims 1
238000001914 filtration Methods 0.000 description 15
239000001963 growth medium Substances 0.000 description 14
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 13
229910052760 oxygen Inorganic materials 0.000 description 13
239000001301 oxygen Substances 0.000 description 13
238000004113 cell culture Methods 0.000 description 9
239000000463 material Substances 0.000 description 7
239000000725 suspension Substances 0.000 description 7
239000000706 filtrate Substances 0.000 description 5
239000002245 particle Substances 0.000 description 5
230000001954 sterilising effect Effects 0.000 description 5
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
230000002779 inactivation Effects 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
239000012528 membrane Substances 0.000 description 4
238000005086 pumping Methods 0.000 description 4
239000002002 slurry Substances 0.000 description 4
238000004114 suspension culture Methods 0.000 description 4
OTIXUSNHAKOJBX-UHFFFAOYSA-N 1-(aziridin-1-yl)ethanone Chemical compound CC(=O)N1CC1 OTIXUSNHAKOJBX-UHFFFAOYSA-N 0.000 description 3
102100034274 Diamine acetyltransferase 1 Human genes 0.000 description 3
241000710198 Foot-and-mouth disease virus Species 0.000 description 3
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
101000641077 Homo sapiens Diamine acetyltransferase 1 Proteins 0.000 description 3
101000713305 Homo sapiens Sodium-coupled neutral amino acid transporter 1 Proteins 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
239000012876 carrier material Substances 0.000 description 3
238000011109 contamination Methods 0.000 description 3
239000011521 glass Substances 0.000 description 3
239000000758 substrate Substances 0.000 description 3
102100031974 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 Human genes 0.000 description 2
241000699800 Cricetinae Species 0.000 description 2
241000272184 Falconiformes Species 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
101000703754 Homo sapiens CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 Proteins 0.000 description 2
101000640813 Homo sapiens Sodium-coupled neutral amino acid transporter 2 Proteins 0.000 description 2
101000716973 Homo sapiens Thialysine N-epsilon-acetyltransferase Proteins 0.000 description 2
102100020926 Thialysine N-epsilon-acetyltransferase Human genes 0.000 description 2
239000001569 carbon dioxide Substances 0.000 description 2
229910002092 carbon dioxide Inorganic materials 0.000 description 2
230000010261 cell growth Effects 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
230000001276 controlling effect Effects 0.000 description 2
239000012531 culture fluid Substances 0.000 description 2
230000000120 cytopathologic effect Effects 0.000 description 2
-1 diatomaceous earth silicates Chemical class 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
238000004090 dissolution Methods 0.000 description 2
239000007789 gas Substances 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
238000004062 sedimentation Methods 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
239000000243 solution Substances 0.000 description 2
229910001220 stainless steel Inorganic materials 0.000 description 2
239000010935 stainless steel Substances 0.000 description 2
238000004659 sterilization and disinfection Methods 0.000 description 2
238000003756 stirring Methods 0.000 description 2
238000012360 testing method Methods 0.000 description 2
241000272478 Aquila Species 0.000 description 1
241000537222 Betabaculovirus Species 0.000 description 1
208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
241000257303 Hymenoptera Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
229920000297 Rayon Polymers 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
238000010793 Steam injection (oil industry) Methods 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
239000010425 asbestos Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000000721 bacterilogical effect Effects 0.000 description 1
239000007640 basal medium Substances 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000019522 cellular metabolic process Effects 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
238000012864 cross contamination Methods 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
239000012530 fluid Substances 0.000 description 1
238000005187 foaming Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
238000007710 freezing Methods 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
DOHGPSDHRIKTDB-KBAHWNQNSA-N galmic Chemical compound O=C([C@@]1(C)C2=NC(=C(O2)C)C(=O)N[C@](C)(C2=NC(=C(O2)C)C(=O)N[C@@](C2=NC(=C(O2)C)C(=O)N1)(C)C(=O)N[C@@H](CCCCN)C(=O)OC)C(=O)NC1C2=CC=CC=C2C2=CC=CC=C21)NCC1CCCCC1 DOHGPSDHRIKTDB-KBAHWNQNSA-N 0.000 description 1
108010036472 galmic Proteins 0.000 description 1
239000003365 glass fiber Substances 0.000 description 1
230000005484 gravity Effects 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
230000006698 induction Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
230000021121 meiosis Effects 0.000 description 1
230000011278 mitosis Effects 0.000 description 1
239000000203 mixture Substances 0.000 description 1
238000004264 monolayer culture Methods 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
238000011045 prefiltration Methods 0.000 description 1
239000000047 product Substances 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
239000002964 rayon Substances 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
210000004994 reproductive system Anatomy 0.000 description 1
229910052895 riebeckite Inorganic materials 0.000 description 1
239000002689 soil Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
241000894007 species Species 0.000 description 1
239000004575 stone Substances 0.000 description 1
229920002994 synthetic fiber Polymers 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
229960004854 viral vaccine Drugs 0.000 description 1
239000002351 wastewater Substances 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
239000002023 wood Substances 0.000 description 1

Landscapes

Micro-Organisms Or Cultivation Processes Thereof (AREA)

DK55175A 1972-04-26 1975-02-14 Fremgangsmåde til fremstilling af en vaccine ved dyrkning af mikroorganismer, navnlig virus, i eucaryotiske celler. DK142343B (da)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
DK55175A DK142343B (da)	1972-04-26	1975-02-14	Fremgangsmåde til fremstilling af en vaccine ved dyrkning af mikroorganismer, navnlig virus, i eucaryotiske celler.

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
GB1938772		1972-04-26
GB1938772A GB1436323A (en)	1972-04-26	1972-04-26	Cell and virus culture systems
DK226173AA DK141911B (da)	1972-04-26	1973-04-25	Celle-dyrkningssystem omfattende levende eucaryotiske celler.
DK226173		1973-04-25
DK55175		1975-02-14
DK55175A DK142343B (da)	1972-04-26	1975-02-14	Fremgangsmåde til fremstilling af en vaccine ved dyrkning af mikroorganismer, navnlig virus, i eucaryotiske celler.

Publications (3)

Publication Number	Publication Date
DK55175A DK55175A (xx)	1975-08-04
DK142343B true DK142343B (da)	1980-10-20
DK142343C DK142343C (xx)	1981-07-20

Family

ID=27220783

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK55175A DK142343B (da)	1972-04-26	1975-02-14	Fremgangsmåde til fremstilling af en vaccine ved dyrkning af mikroorganismer, navnlig virus, i eucaryotiske celler.

Country Status (1)

Country	Link
DK (1)	DK142343B (xx)

1975
- 1975-02-14 DK DK55175A patent/DK142343B/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK142343C (xx)	1981-07-20
DK55175A (xx)	1975-08-04

Publication	Publication Date	Title
US9957485B2 (en)	2018-05-01	Systems and methods for virus propagation in cell cultures for vaccine manufacture
US5811274A (en)	1998-09-22	Methods, compositions and apparatus for cell transfection
US4203801A (en)	1980-05-20	Cell and virus culture systems
JP2019523002A (ja)	2019-08-22	交互タンジェンシャルフローによる高速収穫
US10851350B1 (en)	2020-12-01	Bioreactor production of virus from adherent cells
RU2099419C1 (ru)	1997-12-20	Способ выращивания вирусов
JPS61257181A (ja)	1986-11-14	動物細胞の培養装置
CA2074824C (en)	2001-04-17	Process for depleting viruses in solutions and for determining the depletion rate of the viruses
JP6758194B2 (ja)	2020-09-23	高細胞密度フィル・アンド・ドロー発酵プロセス
DK141911B (da)	1980-07-14	Celle-dyrkningssystem omfattende levende eucaryotiske celler.
US20210268405A1 (en)	2021-09-02	Method for producing recombinant adenovirus
WO2022262206A1 (zh)	2022-12-22	Gmp级逆转录病毒载体的纯化方法与应用
US4085203A (en)	1978-04-18	Process for preparing vaccine
DK142343B (da)	1980-10-20	Fremgangsmåde til fremstilling af en vaccine ved dyrkning af mikroorganismer, navnlig virus, i eucaryotiske celler.
CN106635891A (zh)	2017-05-10	牛支原体专用快速培养基及牛支原体的分离纯化方法
CN106178163B (zh)	2019-02-01	艾滋病生物细胞免疫治疗仪
JP3641123B2 (ja)	2005-04-20	ウィルスまたは細胞の培養法
US3965258A (en)	1976-06-22	Process for production of vaccines
JPS61192280A (ja)	1986-08-26	連続型微生物培養装置
JP2023544184A (ja)	2023-10-20	接着細胞からのウイルスのバイオリアクター生成
RU2664729C1 (ru)	2018-08-22	Способ очистки сыворотки крови крупного рогатого скота от контаминирующих агентов
Weiss	1980	Concentration of baboon endogenous virus in large‐scale production by use of hollow‐fiber ultrafiltration technology
CN111690608A (zh)	2020-09-22	一种双抗体联合胸腺肽体外培养nk细胞试剂及试剂盒和培养方法
CN106267415B (zh)	2019-01-22	艾滋病净化治疗仪
Shibley et al.	1980	New method for large-scale growth; and concentration of the Epstein-Barr viruses

Legal Events

Date	Code	Title	Description
1986-12-22	PBP	Patent lapsed